Eyeing The Future: AstraZeneca Farms Out Compounds To Ocular Specialist Alcon
This article was originally published in The Pink Sheet Daily
Executive Summary
Alcon's now-tenuous relationship with Novartis is unlikely to affect the new five-year research agreement with AstraZeneca.